Article Versions Notes

Yuan L, Mishra R, Patel H, Alanazi S, Wei X, Ma Z, Garrett JT. BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels. Cancers. 2020; 12(6):1661. https://doi.org/10.3390/cancers12061661

Yuan, Long, Rosalin Mishra, Hima Patel, Samar Alanazi, Xin Wei, Zhijun Ma, and Joan T. Garrett. 2020. "BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels" Cancers 12, no. 6: 1661. https://doi.org/10.3390/cancers12061661

Yuan, L., Mishra, R., Patel, H., Alanazi, S., Wei, X., Ma, Z., & Garrett, J. T. (2020). BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels. Cancers, 12(6), 1661. https://doi.org/10.3390/cancers12061661